Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRDX | Common Stock | Award | $0 | +1.38K | +16.58% | $0.00 | 9.67K | Feb 10, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SRDX | Stock Option (right to buy) | Award | $0 | +3.56K | $0.00 | 3.56K | Feb 10, 2022 | Common Stock | 3.56K | $41.81 | Direct | F2 |
Id | Content |
---|---|
F1 | The amount beneficially owned includes 6,316 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends. |
F2 | The stock options vest ratably on a monthly basis and become fully vested on February 10, 2023, the 12-month anniversary of the grant date. |